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Summary
Objective: The purpose of this study was to determine the effects of intra-articular injections of high molecular weight (2000 kDa) sodium
hyaluronate (HA) on the progression of articular cartilage degeneration in a rabbit partial medial meniscectomy model of osteoarthritis.
Design: Six experimental groups included normal, sham operated, and operated and injected animals, the latter injected once-weekly (for
two weeks or twelve weeks, beginning four weeks after surgery) with either 1% (w/v) HA or phosphate buffered saline (PBS). Following
assessment of gross morphology, serial adjacent blocks of full-depth articular cartilage were prepared from the tibial condyle for analysis of
total water, hydroxyproline, DNA and proteoglycan (uronic acid) content, as well as the ratio of galactosamine to glucosamine. Samples were
sub-divided into inner (medial) and outer (lateral) regions.
Results: No morphological differences were recognized between joints injected with PBS and those receiving HA. When analysed
biochemically, there were no significant differences in hydration, hydroxyproline or DNA content between the experimental groups. In
contrast, HA injection did affect changes in proteoglycan content. Expressed per tissue dry weight, uronic acid content in the operated group
injected with PBS for two weeks was lower than normal (P<0.02), a result not seen in the corresponding HA injected group. After 12 weeks
of PBS injections, uronic acid content (per dry weight) was higher than normal (P<0.01), an effect again not observed in the corresponding
HA injected group. Results for the galactosamine: glucosamine ratio showed a reduction after 12 weeks of injections, but no differences
between PBS and HA injected groups.
Conclusions: Once-weekly, intra-articular injection of high molecular weight HA can prevent changes in proteoglycan content in tibial
condylar articular cartilage, compared to PBS injected controls, in the rabbit partial meniscectomy model of osteoarthritis.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
Osteoarthritis (OA) is characterized by the progressive
degeneration of articular cartilage, with an accompanying
re-modeling of both cartilage and bone1,2. An early event in
the pathogenesis of OA is a loss of hyaluronate (HA) from
the synovial fluid, together with a decrease in its average
molecular weight3. These changes in HA result in a marked
diminution in the rheological properties of the synovial fluid,
which may lead to degeneration or re-modeling of the
articular cartilage and underlying bone. In order to prevent
these degenerative changes, the concept of visco-
supplementation was introduced by Balazs and col-
leagues3, in which exogenous hyaluronate is injected
intraarticularly into the joint. Though intra-articular injection
with HA is becoming increasingly widespread in the treat-
ment of knee OA4,5, its efficacy remain controversial6–11.
Recommendations differ in the number and frequency of
injections required to bring about significant improvement,
and the molecular weight (MW) of the HA used is clearly an
important factor12.
Many animal models of osteoarthritis have been devel-
oped. These include transection of the anterior cruciate
ligament in dogs13–18, rabbits19 and rats20. Further
rabbit models include joint immobilization21,22 or partial
meniscectomy23–25, sometimes combined with ligament
transection26. Total meniscectomy models have also been
used in rabbits27,28 and sheep29,30. Here we report the
effects of intraarticular, high MW (2000 kDa) HA injections
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on biochemical composition of rabbit articular cartilage in a
partial meniscectomy model of OA24.
Materials and methods
Eighty-four mature New Zealand white rabbits of mean
weight 3.0 kg were obtained from an accredited supplier
and maintained on a balanced diet under Home Office-
approved conditions. Seventy-eight of these animals were
selected for the present study.
SURGICAL PROCEDURE
Pilot studies showed that a modified Hulth31 procedure
caused cartilage disease of such severity that sensitive
histological and cytological analyses were not practicable.
To promote milder disease, the right knee joints of 60
rabbits were therefore subjected only to partial meniscec-
tomy. The anteromedial capsule of the right knee was
opened and the medial meniscus identified. Release of the
medial collateral ligament gave access to the posterior part
of the capsule. All capsular attachments of the medial
meniscus were freed. The meniscus was retracted from the
joint and the posterior meniscotibial ligament divided. The
greater part of the meniscus was removed from the joint.
Care was taken at all times to avoid contact between the
instruments and articular surfaces. The joint capsule was
repaired, the skin closed and a well-padded dressing
applied. The joint was left stable to both valgus and varus
movement and to anteroposterior stressing. The animals
were maintained in large cages for the first 24 h postopera-
tively. In a sham operation, a surgical incision was made
into the knee joints of a further 12 animals without excising
a meniscus. Six animals were retained as normal controls.
HA INJECTIONS
Further pilot studies demonstrated that a period of at
least 3 weeks was necessary before the knee joints of
operated animals could be injected safely with viscous HA.
Without this precaution, the polymer was found to escape
from the joint into adjacent soft tissues, predisposing to
infection. Thirty operated animals were therefore injected
once weekly intra-articularly with sterile, 0.5 ml endotoxin-
free, 1% w/v sodium hyaluronate solution (Fermentech
Medical Ltd), molecular mass 2×106 Da (obtained by bac-
terial fermentation of Streptococcus equi), in phosphate
buffered saline (PBS), pH 7.2, beginning 4 weeks after
surgery. Injections were given for 2 weeks to 15 rabbits and
for 12 weeks to the remaining 15. Thirty further animals
were injected in the same way once weekly with 0.5 ml
sterile PBS, pH 7.20, 15 for 2 weeks and 15 for 12 weeks.
TISSUE COLLECTION
Both right and left knee joints were studied in the normal
control group (6 rabbits). The right knee joints of the
sham-operated group (12 rabbits) were analysed at the end
of the 4 week recovery period.
Animals were sacrificed by intravenous injection of
pentobarbitone. The lower limbs were excised and placed
on ice. The right knee joints were opened through a lateral
incision, the cruciate and collateral ligaments divided and
each femur separated from the corresponding tibia. After
removal of the lateral meniscus and the remaining part of
the medial meniscus, the tibial condylar cartilages were
excised superficial to the calcified cartilage zone. With a
dissecting microscope and ophthalmic scalpel, a circumfer-
ential incision encircled the lateral and medial aspects of
the tibial condyle. Nine to 11 perpendicular incisions were
made in the coronal plane across each condylar cartilage,
commencing posteriorly. The blocks thus defined
were undercut, allowing ∼7.0×0.9×0.5 mm samples to be
removed. Blocks were pooled and immediately placed in
pre-weighed, sealed containers that were previously
humidified with moist tissue paper.
BIOCHEMICAL PROCEDURES
Coronal blocks of articular cartilage, selected as above,
were bisected sagitally in a humidified environment. The
first sample from each specimen therefore represented the
relatively thick, inner (medial) region of the tibial condylar
cartilage normally covered by a relatively thin part of the
meniscus whereas the second sample represented the
thin, outer (lateral) region normally covered by a relatively
thick part of the meniscus. Each sample was then weighed
quickly before being dried, in a 60°C oven for 4 h, to
constant weight. Dried cartilage samples (3–25 mg dry
weight) were solubilized by sodium dodecyl sulphate and
proteinase K digestion, as described32. Following diges-
tion, DNA, uronic acid, hydroxyproline content, as well
as galactosamine/glucosamine ratios, were determined as
below.
Hexuronic acid was determined by a modification of the
carbazole method of Bitter and Muir33,34. To prevent
caramelization of carbohydrate, the borate/sulphuric acid
solution was cooled to −30°C before the addition of sample
or glucurolactone standard. Total DNA content was deter-
mined by the Hoechst 33258 fluorescent dye-binding tech-
nique32. For hydroxyproline analysis, digests were
hydrolysed in 6 M HCl in sealed tubes for 16 h at 100°C.
After removal of HCl by evaporation in a SpeedVac con-
centrator, hydroxyproline was determined colorimetrically
after chloramine T oxidation and subsequent reaction
with p-dimethylaminobenzaldehyde35. Galactosamine/
glucosamine ratios were determined36 following hydrolysis
of cartilage digests in 2M trifluoroacetic acid (TFA) for 4 h at
100°C. The TFA was removed by evaporation and amino
sugars separated by HPLC on a Dionex CarboPac PA1
analytical column (4×250 mm) with pulsed amperometric
detection using a gold electrode.
STATISTICAL ANALYSIS
Statistical analysis was initially by single factor analysis
of variance (ANOVA), comparing the six experimental
groups for each measured variable, with results for inner
and outer regions treated separately, followed by compari-
sons of means using a two-tailed Student’s t test. Statistical
significance was taken as P<0.05.
Results
MORPHOLOGY
The appearances of the opened, untouched control knee
joints were uniformly normal. The knee joints of the animals
subjected to a sham operation revealed only the external,
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sutured surgical incisions together with slight oedema of
the subcutaneous connective tissue. In the case of the
animals examined 6 weeks after surgery, the soft tissues
around the knee joint were still slightly swollen. Within the
joints, occasional orange coloration of the synovia con-
firmed the bleeding that had taken place into the joints
when the capsules were incised. The greater part, but
never all, of the medial menisci had been removed. The
bearing surfaces of the lateral condyles did not differ from
normal. Sixteen weeks after operation, rare flecks of white,
granular material were seen on the surfaces of the medial
condyles and the cartilage was often softer than normal.
There were no significant differences in appearance
between the joints of animals injected with PBS and those
receiving HA.
BIOCHEMICAL COMPOSITION
The results (Figs. 1–6) include data from both inner
(thick, medial) and outer (thin, lateral) regions of the tibial
medial condyle. For each experimental group, results are
shown in the following order: (i) normal, unoperated (N), (ii)
sham operated (S), (iii) operated controls, injected with
PBS for two weeks (PBS2), (iv) operated and injected with
HA for two weeks (HA2), (v) operated controls, injected
with PBS for 12 weeks (PBS12), and (vi) operated and
injected with HA for 12 weeks (HA12).
There were no significant differences in hydration, com-
pared to normal, in any of the experimental groups, either in
the inner or outer regions of the medial condyle (Fig. 1). It
is notable, however, that in both regions the highest water
content was observed in the operated controls injected with
PBS for 12 weeks (i.e. 16 weeks after surgery) while in the
corresponding HA injected samples, water content was
lower. There were also no significant differences in collagen
content (measured as hydroxyproline per dry weight), com-
pared to normal, in any of the experimental groups (Fig. 2).
In the inner region only, DNA content in the PBS injected
control groups, after both two weeks and 12 weeks, was
lower than normal, unlike the HA injected groups, though
these differences were not significant (Fig. 3). There were
no significant differences in hydration, hydroxyproline or
DNA content between normal and sham-operated controls,
in both inner and outer regions.
When expressed per dry weight of cartilage (Fig. 4), the
amounts of uronic acid in normal and sham operated
samples were similar, in both inner and outer regions. After
2 weeks of injections (i.e. 6 weeks after surgery), amounts
in operated controls (injected with PBS) were significantly
lower than normal (P<0.001, for both inner and outer
regions), as was the amount of uronic acid in the outer
region of the HA injected group (P<0.01), though the uronic
acid content of the inner region of the HA injected group
appeared normal. After 12 weeks of injections (i.e. 16
weeks after surgery), there was an increase in uronic acid
content in the PBS injected samples from the inner region,
compared to normal (P<0.02), though this was not
observed in the corresponding HA injected samples. In the
outer region, the amount of uronic acid (per dry weight) in
the PBS injected group was indistinguishable from normal,
though the amount in the corresponding HA injected group
Fig. 1. Hydration (water content) of articular cartilage from the
medial tibial condyle (inner and outer regions) in the six exper-
imental groups. Error bars indicate one standard error of the mean.
N: normal controls; S: sham operated animals; PBS2: animals
injected for 2 weeks with intra-articular phosphate buffered saline;
HA2: animals injected for 2 weeks with intra-articular sodium
hyaluronate; PBS12: animals injected for 12 weeks with intra-
articular phosphate buffered saline; HA12: animals injected for 12
weeks with intra-articular sodium hyaluronate.
Fig. 2. Hydroxyproline content of articular cartilage (per tissue dry
weight) from the medial tibial condyle (inner and outer regions) in
the six experimental groups. Error bars indicate one standard error
of the mean.
Fig. 3. DNA content of articular cartilage (per tissue dry weight)
from the medial tibial condyle (inner and outer regions) in the six
experimental groups. Error bars indicate one standard error of the
mean.
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was low (P=0.03, compared to normal). It should be noted
that the increases in uronic acid after 12 weeks were
observed in the operated controls (injected with PBS),
rather than the HA injected samples, despite the fact that
uronic acid is a constituent of HA.
When uronic acid was expressed per total DNA (Fig. 5),
the decrease observed in Fig. 4 in the operated controls
after 2 weeks PBS injections was no longer apparent. The
major observation was a large increase in the amount of
uronic acid after 12 weeks with PBS, particularly in the
inner region (P<0.001, compared to normal), which was not
seen in the HA injected samples.
The ratio of galactosamine to glucosamine after 12
weeks of injections was significantly lower than normal
(P<0.01, in both inner and outer regions), though there
were no differences between the PBS and HA injected
groups (Fig. 6).
Discussion
CHANGES IN ARTICULAR CARTILAGE COMPOSITION
Biochemical changes occurring during OA represent
more than the mere passive degeneration of the articular
cartilage. For example, loss of/damage to the cartilage in
human OA is associated with increased synthesis as well
as increased degradation of collagens, such that total
amounts remain essentially unchanged37. Similar obser-
vations have been made in a number of rabbit models,
including joint immobilization38, total meniscectomy27 and
the partial meniscectomy model used here23. Our obser-
vations that net collagen levels remained essentially
unchanged throughout the study are consistent with this
earlier work, though any changes in rates of synthesis and
degradation were not addressed here.
Though proteoglycan loss is a characteristic feature of
long term cartilage degeneration, transient increases in
proteoglycan levels, as observed here 16 weeks after
surgery, are frequently observed. Increased proteoglycan
synthesis rates have been reported in human OA39, though
there are considerable anatomical variations in this par-
ameter40. There are also anatomical variations in total
uronic acid content, as in the canine femoral condyle where
the uronic acid content (per tissue dry weight) of unloaded
regions is 20% lower than in loaded regions, while both
water and DNA content are relatively uniform41. In the
Pond-Nuki dog model of OA, McDevitt and Muir14 reported
no change in uronic acid levels in tibial articular cartilage up
to 9 weeks after surgery, but increased levels (per tissue
dry weight, compared to unoperated controls) after 48
weeks. Others16,17, using the same dog model, also
found increases in proteoglycan content, indicative of
hypertrophic repair, followed (after 45 months) by cartilage
loss. An increase in uronic acid content (per tissue dry
weight) in the articular cartilage of the tibial plateau was
also reported21 after 6 weeks immobilization of the rabbit
knee.
In the rabbit partial meniscectomy model, the rate of
proteoglycan synthesis is maximal 12 weeks after sur-
gery24, even though (in PBS injected joints) there appears
to be a reduction in the total amount of uronic acid (per
Fig. 4. Uronic acid content of articular cartilage (per tissue dry
weight) from the medial tibial condyle (inner and outer regions) in
the six experimental groups. Error bars indicate one standard error
of the mean, and significant changes (compared to normals) are
indicated (*P<0.02; **P<0.001).
Fig. 5. Uronic acid content of articular cartilage (per µg DNA) from
the medial tibial condyle (inner and outer regions) in the six
experimental groups. Error bars indicate one standard error of the
mean, and significant changes (P<0.001, compared to normals)
are indicated (**).
Fig. 6. Galactosamine/ glucosamine ratio in articular cartilage from
the medial tibial condyle (inner and outer regions) in the six
experimental groups. Error bars indicate one standard error of the
mean, and significant changes (P<0.01, compared to normals) are
indicated (*).
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tissue wet weight) at this time point42. After total meniscec-
tomy in rabbits, Hoch et al.43 reported a fall in uronic acid
content, compared to the non-operated contralateral joint,
two weeks after surgery, which gradually recovered to
normal levels after 26 weeks. The results reported here
appear to conflict with this earlier work, since we observed
a marked increase in uronic acid content (per tissue dry
weight) 16 weeks after surgery in the PBS injected group.
Several factors might account for this variation. First, we
observed a reduction in uronic acid content 6 weeks after
surgery, followed by an increase after 16 weeks. Thus the
timing of the tissue sampling is important. Second, results
expressed per tissue wet weight can be misleading if there
are also changes in water content, as suggested by the
results in Fig. 1. Third, the use of the non-operated contra-
lateral joint can also be misleading, since altered load
bearing and/or systemic factors can also give rise to
biochemical changes in the articular cartilage. Fourth, the
progression of joint degeneration may be influenced by
differences in the surgical procedure.
The ratio of galactosamine to glucosamine in articular
cartilage extracts is a measure of the chondroitin sulphate/
keratan sulphate ratio. Increased galactosamine/ glucosa-
mine ratios have been reported in the Pond-Nuki
dog model of OA14. Similar observations have been
reported in the rabbit meniscectomy model27, where the
galactosamine/glucosamine ratio in the medial tibial pla-
teau reaches a maximum 5 weeks after surgery, falling
thereafter. The observed fall in the galactosamine: glucosa-
mine ratio between 6 weeks after 16 weeks after surgery
(Fig. 6) is therefore consistent with earlier observations.
EFFECTS OF HA INJECTIONS
Studies on the biochemical effects of intra-articular HA on
articular cartilage composition have been carried out using
the anterior cruciate ligament transection model in
dogs44,45 and rabbits46–48, the rabbit immobilization21
and partial meniscectomy49 models and the sheep total
meniscectomy model50.
In the anterior cruciate ligament transection dog model,
the known increase in proteoglycan extractability14
appeared to be partially prevented by weekly injections of
HA (MW 750 kDa)44. Also in dogs, uronic acid concen-
tration increased 30–60% in PBS injected compared to non
operated joints, while HA (MW 1500 kDa) injected joints
showed a 10–30% reduction45. These results are similar to
those reported here (Figs. 4 and 5), where HA injection
appeared to prevent the increase in uronic acid content in
PBS injected joints 16 weeks after surgery. Similarly, in the
rabbit knee immobilization model21 a single injection of
high MW HA prevented the increase in uronic acid content
(per tissue dry weight) in the tibial plateau after 6 weeks
immobilization. In the sheep medial meniscectomy
model50, weekly intra-articular injections of HA led to
reduced proteoglycan synthesis and increased turnover,
and the effects were greater with high MW (2000 kDa)
compared low MW (800 kDa) HA.
In addition to the increase in uronic acid content
observed 16 weeks after surgery in cartilage from the PBS
injected joints, we also observed a drop in uronic acid
content (per mg dry weight) 6 weeks after surgery (Fig. 4).
This drop also appeared to prevented by HA injection. This
result is similar to that observed using a rabbit anterior
cruciate ligament transection model, using low MW
(800 kDa) HA, where the femoral condyle cartilage was
analysed 9 weeks after surgery46.
The possibility that PBS injection may exacerbate the
effects introduced by partial meniscectomy must be con-
sidered. It has been reported that excessive use of saline
during arthroscopic procedures can have a deleterious
effect upon chondrocyte metabolism51. Most recent studies
on the effects of intra-articular HA in animal models have
used PBS injection as controls19,22,45,47,49,50,52. An excep-
tion, however, is the work of Yoshioka et al.46, who com-
pared the effects of HA injections with PBS injected and
non-injected operated controls following anterior cruciate
ligament transection in rabbits. Similar results were
obtained with PBS injected and non-injected controls, thus
indicating that HA injection had a real effect on preventing
changes in cartilage composition.
HA has numerous biological effects12,53–55, involving
interactions with specific cellular receptors56. It mediates
the production of inflammatory mediators, is an effective
scavenger of free radicals and an inhibitor of leukocyte
adhesion, chemotaxis and phagocytosis. In addition, it can
modulate cell migration, proliferation, apoptosis, aggre-
gation and differentiation. Exogenous HA can also up- or
down-regulate synthesis of endogenous HA, depending on
MW57, and can prevent degradation and cytokine induced
release of proteoglycans into the extracellular matrix58.
Some or all of these phenomena may be involved in the
observed effect of exogenous HA on proteoglycan content
in this rabbit model of OA.
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